BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 12857747)

  • 1. Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate.
    Campbell RB; Liu F; Ross AH
    J Biol Chem; 2003 Sep; 278(36):33617-20. PubMed ID: 12857747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipid-binding sites of phosphatase and tensin homolog (PTEN): exploring the mechanism of phosphatidylinositol 4,5-bisphosphate activation.
    Wei Y; Stec B; Redfield AG; Weerapana E; Roberts MF
    J Biol Chem; 2015 Jan; 290(3):1592-606. PubMed ID: 25429968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A voltage-sensing phosphatase, Ci-VSP, which shares sequence identity with PTEN, dephosphorylates phosphatidylinositol 4,5-bisphosphate.
    Iwasaki H; Murata Y; Kim Y; Hossain MI; Worby CA; Dixon JE; McCormack T; Sasaki T; Okamura Y
    Proc Natl Acad Sci U S A; 2008 Jun; 105(23):7970-5. PubMed ID: 18524949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
    Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN phosphatase selectively binds phosphoinositides and undergoes structural changes.
    Redfern RE; Redfern D; Furgason ML; Munson M; Ross AH; Gericke A
    Biochemistry; 2008 Feb; 47(7):2162-71. PubMed ID: 18220422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.
    Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP
    Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the PTEN phosphatase.
    Gericke A; Munson M; Ross AH
    Gene; 2006 Jun; 374():1-9. PubMed ID: 16675164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PTEN-like phosphatase with a novel substrate specificity.
    Pagliarini DJ; Worby CA; Dixon JE
    J Biol Chem; 2004 Sep; 279(37):38590-6. PubMed ID: 15247229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide 5- and 3-phosphatase activities of a voltage-sensing phosphatase in living cells show identical voltage dependence.
    Keum D; Kruse M; Kim DI; Hille B; Suh BC
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3686-95. PubMed ID: 27222577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of PTEN-mediated PI(3,4,5)P3 hydrolysis on solid supported membranes.
    Liu C; Deb S; Ferreira VS; Xu E; Baumgart T
    PLoS One; 2018; 13(2):e0192667. PubMed ID: 29447222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal tail inhibitory phosphorylation sites of PTEN regulate its intrinsic catalytic activity and the kinetics of its binding to phosphatidylinositol-4,5-bisphosphate.
    Chia YC; Catimel B; Lio DS; Ang CS; Peng B; Wu H; Zhu HJ; Cheng HC
    Arch Biochem Biophys; 2015 Dec; 587():48-60. PubMed ID: 26471078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis.
    Iijima M; Huang YE; Luo HR; Vazquez F; Devreotes PN
    J Biol Chem; 2004 Apr; 279(16):16606-13. PubMed ID: 14764604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel class of PTEN protein in Arabidopsis displays unusual phosphoinositide phosphatase activity and efficiently binds phosphatidic acid.
    Pribat A; Sormani R; Rousseau-Gueutin M; Julkowska MM; Testerink C; Joubès J; Castroviejo M; Laguerre M; Meyer C; Germain V; Rothan C
    Biochem J; 2012 Jan; 441(1):161-71. PubMed ID: 21864294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
    Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
    Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutant form of PTEN linked to autism.
    Redfern RE; Daou MC; Li L; Munson M; Gericke A; Ross AH
    Protein Sci; 2010 Oct; 19(10):1948-56. PubMed ID: 20718038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
    Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
    Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptojanin inhibition of phospholipase D activity by hydrolysis of phosphatidylinositol 4,5-bisphosphate.
    Chung JK; Sekiya F; Kang HS; Lee C; Han JS; Kim SR; Bae YS; Morris AJ; Rhee SG
    J Biol Chem; 1997 Jun; 272(25):15980-5. PubMed ID: 9188500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase.
    Wu Y; Dowbenko D; Pisabarro MT; Dillard-Telm L; Koeppen H; Lasky LA
    J Biol Chem; 2001 Jun; 276(24):21745-53. PubMed ID: 11279206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the membrane-associated state of the PTEN tumor suppressor protein.
    Lumb CN; Sansom MS
    Biophys J; 2013 Feb; 104(3):613-21. PubMed ID: 23442912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.